This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011;20(1):1-3.

doi: 10.1159/000319928. Epub 2010 Dec 13.

The role of nanobiotechnology in the development of personalized medicine

K K Jain¹

Affiliations

PMID: 21160206
DOI: 10.1159/000319928

Free article

The role of nanobiotechnology in the development of personalized medicine

K K Jain. Med Princ Pract. 2011.

Free article

. 2011;20(1):1-3.

doi: 10.1159/000319928. Epub 2010 Dec 13.

Author

K K Jain¹

Affiliation

¹ Jain PharmaBiotech, Basel, Switzerland. jain @ pharmabiotech.ch

PMID: 21160206
DOI: 10.1159/000319928

No abstract available

PubMed Disclaimer

Similar articles

Nanobiotechnology and personalized medicine.
Jain KK. Jain KK. Prog Mol Biol Transl Sci. 2011;104:325-54. doi: 10.1016/B978-0-12-416020-0.00008-5. Prog Mol Biol Transl Sci. 2011. PMID: 22093223 Review.
The role of nanobiotechnology in drug discovery.
Jain KK. Jain KK. Drug Discov Today. 2005 Nov 1;10(21):1435-42. doi: 10.1016/S1359-6446(05)03573-7. Drug Discov Today. 2005. PMID: 16243263 Review.
'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems.
Crommelin DJ, Storm G, Luijten P. Crommelin DJ, et al. Int J Pharm. 2011 Aug 30;415(1-2):5-8. doi: 10.1016/j.ijpharm.2011.02.010. Epub 2011 Feb 12. Int J Pharm. 2011. PMID: 21320581
Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
Jain KK. Jain KK. Nanomedicine (Lond). 2011 Apr;6(3):411-4. doi: 10.2217/nnm.11.12. Nanomedicine (Lond). 2011. PMID: 21542679 No abstract available.
Role of nanobiotechnology in the development of personalized medicine.
Jain KK. Jain KK. Nanomedicine (Lond). 2009 Apr;4(3):249-52. doi: 10.2217/nnm.09.12. Nanomedicine (Lond). 2009. PMID: 19331532 No abstract available.

See all similar articles

Cited by

Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.
Chiorean L, Tana C, Braden B, Caraiani C, Sparchez Z, Cui XW, Baum U, Dietrich CF. Chiorean L, et al. Med Princ Pract. 2016;25(5):399-407. doi: 10.1159/000447670. Epub 2016 Jun 17. Med Princ Pract. 2016. PMID: 27318740 Free PMC article. Review.
Personalized Management of Cardiovascular Disorders.
Jain KK. Jain KK. Med Princ Pract. 2017;26(5):399-414. doi: 10.1159/000481403. Epub 2017 Sep 11. Med Princ Pract. 2017. PMID: 28898880 Free PMC article. Review.
Superparamagnetic iron oxide-enhanced magnetic resonance imaging in a case of spleen hamartoma.
Bulakci M, Yilmaz E, Yahyayev A, Bulakci BB, Yekeler E. Bulakci M, et al. Med Princ Pract. 2013;22(3):301-3. doi: 10.1159/000343577. Epub 2012 Oct 27. Med Princ Pract. 2013. PMID: 23107785 Free PMC article.
Emerging metrology for high-throughput nanomaterial genotoxicology.
Nelson BC, Wright CW, Ibuki Y, Moreno-Villanueva M, Karlsson HL, Hendriks G, Sims CM, Singh N, Doak SH. Nelson BC, et al. Mutagenesis. 2017 Jan;32(1):215-232. doi: 10.1093/mutage/gew037. Epub 2016 Aug 26. Mutagenesis. 2017. PMID: 27565834 Free PMC article. Review.
Synthetic biology and personalized medicine.
Jain KK. Jain KK. Med Princ Pract. 2013;22(3):209-19. doi: 10.1159/000341794. Epub 2012 Aug 16. Med Princ Pract. 2013. PMID: 22907209 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland